Caroline Young - Net Worth and Insider Trading

Caroline Young Net Worth

The estimated net worth of Caroline Young is at least $155,806 dollars as of 2025-05-02. Caroline Young is the Director of Cumberland Pharmaceuticals Inc and owns about 32,392 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $155,806. Details can be seen in Caroline Young's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Caroline Young has not made any transactions after 2025-03-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Caroline Young

To

Caroline Young Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Caroline Young owns 1 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) .

Click here to see the complete history of Caroline Young’s form 4 insider trades.

Insider Ownership Summary of Caroline Young

Ticker Company Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2025-03-31 director

Caroline Young Latest Holdings Summary

Caroline Young currently owns a total of 1 stock. Caroline Young owns 32,392 shares of Cumberland Pharmaceuticals Inc (CPIX) as of March 31, 2025, with a value of $155,806.

Latest Holdings of Caroline Young

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPIX Cumberland Pharmaceuticals Inc 2025-03-31 32,392 4.81 155,806

Holding Weightings of Caroline Young


Caroline Young Form 4 Trading Tracker

According to the SEC Form 4 filings, Caroline Young has made a total of 20 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 20 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 74 shares on March 31, 2025, which cost Caroline Young around $383.

Insider Trading History of Caroline Young

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Caroline Young Trading Performance

GuruFocus tracks the stock performance after each of Caroline Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caroline Young is 24.63%. GuruFocus also compares Caroline Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caroline Young within 3 months outperforms 12 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Caroline Young's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Caroline Young

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 18 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.18 LIMIT LIMIT LIMIT LIMIT LIMIT

Caroline Young Ownership Network

Ownership Network List of Caroline Young

No Data

Ownership Network Relation of Caroline Young

Insider Network Chart

Caroline Young Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

Caroline Young is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO A J Kazimi , Vice Pres Sales & Marketing Chris T. Bitterman , and Vice Pres Organizational Dev Todd M. Anthony .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, Caroline Young made 4 insider transaction in Cumberland Pharmaceuticals Inc (CPIX) with a net purchase of 1,588. Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 20,727 shares made by Kenneth Krogulski , a net purchase of 3,869 shares made by A J Kazimi , and a net purchase of 3,869 shares made by James Jones .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 1,285 shares, with a net purchase of 1,285 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 30,053 shares were bought by its insiders, resulting in a net purchase of 30,053 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

Caroline Young Mailing Address

Above is the net worth, insider trading, and ownership report for Caroline Young. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Caroline Young's mailing address is: Nashville Tn 37203.